Evidence map›Paper›PMID 33841537›Full record

ArticleIranian journal of pharmaceutical research : IJPR2020

Anti-cholinesterase and Neuroprotective Activities of Sweet and Bitter Apricot Kernels (

Yasaman Vahedi-Mazdabadi, Elahe Karimpour-Razkenari, Tahmineh Akbarzadeh, Hania Lotfian, Mohammad Toushih, Neda Roshanravan, Mina Saeedi, Alireza Ostadrahimi

Abstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Frontiers in pharmacology · 2024
    Review
  6. Article
  7. Molecular Mechanisms and Pathophysiological Significance of Eryptosis.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Phytochemical Analysis and Evaluation of Biological Activity ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yasaman Vahedi-MazdabadiNutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Elahe Karimpour-RazkenariPersian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Tahmineh AkbarzadehPersian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hania LotfianDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad ToushihElectrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Neda RoshanravanCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mina SaeediMedicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Alireza OstadrahimiNutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apricot (

Indexed as

Alzheimer’s diseaseAmygdalinCholinesterase inhibitorsNeuroprotectivityP. armeniaca

Identifiers

PMID33841537
PMCPMC8019877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.